There is increasing interest in the use of mechanism-based multi-scale computational models (such as agent-based models) to generate simulated clinical populations in order to discover and evaluate potential diagnostic and therapeutic modalities. The description of the environment in which a biomedical simulation operates (model context) and parameterization of internal model rules (model content) requires the optimization of a large number of free-parameters. In this work, we utilize a nested active-learning workflow to efficiently parameterize and contextualize an agent-based model (ABM) of systemic inflammation used to examine sepsis. Methods: Contextual parameter space was examined using four parameters external to the model's rule-set. The model's internal parameterization, which represents gene expression and associated cellular behaviors, was explored through the augmentation or inhibition of signaling pathways for 12 signaling mediators associated with inflammation and wound healing. We have implemented a nested active learning approach in which the clinically relevant model environment space for a given internal model parameterization is mapped using a small Artificial Neural Network (ANN). The outer AL level workflow is a larger ANN which uses active learning to efficiently regress the volume and centroid location of the CR space given by a single internal parameterization.
Introduction
There is increasing interest in the use of mechanism-based multi-scale computational models as an aid to more traditional biomedical research methods. This approach integrates existing cellular and molecular mechanistic knowledge into tissue-, organ-and patient-level representations that are used to generate "virtual populations" to investigate potential diagnostic and therapeutic modalities. This is the underlying concept of creating "digital twins" for the study of precision medicine (1)and the regulatory interest in advancing the ability to perform in silico clinical trials (2) . However, achieving these goals involves several significant hurdles related to the complex nature of the biology being studied, the models used to represent that biology, and the contextualization of those models in an approximation of a clinical environment. In this work, we address some of the challenges associated with the use of agent-based models (ABMs) to generate clinically-relevant simulation experiments, specifically those related to the effective and efficient parameterization of complex ABMs and the evaluation of those parameterizations within a clinical context that itself represents a multi-parametric space. We perform this work using a previously validated ABM of acute systemic inflammation (3, 4) while studying the clinical context of sepsis.
Sepsis is an inflammatory condition with a mortality rate of between 28%-50%(5). Numerous mechanistic computational simulations of acute inflammation and sepsis have been utilized over the past two decades (3, (6) (7) (8) (9) (10) (11) (12) . These models have demonstrated that the sepsis population is much more heterogeneous than previously thought and this can be reflected by utilizing a range of multidimensional parameters that correlate to biologically plausible behaviors and phenotypes. Despite insights generated form these methods, there remain considerable challenges in the calibration and parameterization of the models. The description (contextualization) of the environment in which a biomedical simulation operates and parameterization of internal model rules (model content) requires the optimization of a large number of free-parameters; given the wide range of variable combinations, along with the intractability of ab initio modeling techniques which could be used to constrain these combinations, an astronomical number of simulations would be required to achieve this goal.
The primary model analyzed in this work is the Innate Immune Response Agent Based Model (IIRABM) (6, 13) . The IIRABM is an abstract representation/simulation of the human inflammatory signaling network response to injury; the model has been calibrated such that it reproduces the general clinical trajectories seen in sepsis. The IIRABM operates by simulating multiple cell types and their interactions, including endothelial cells, macrophages, neutrophils, TH0, TH1, and TH2 cells as well as their associated precursor cells. The simulated system dies when total damage (defined as aggregate endothelial cell damage) exceeds 80%; this threshold represents the ability of current medical technologies to keep patients alive (i.e., through organ support machines) in conditions that previously would have been lethal. The IIRABM is initiated using 5 external variables -initial injury size, microbial invasiveness, microbial toxigenesis, environmental toxicity, and host resilience.
The model's internal parameterization can be thought of as an abstraction of an in vivo genetic signaling network while the model context defines the simulated injury to which the model responds. This model has successfully replicated the range of cytokine time-course dynamics of sepsis and healing across a wide range of model contexts, however all models have been "genetically identical," analogous to a typical mouse experiment. In practice, we recognize that there are two primary sources of variation in biological data. In any biological system, the response to a given stimulus contains some intrinsic degree of stochasticity -this can be seen in the range of responses from genetically identical mice to identical stimuli. Alternatively, variance in biological data output can arise from the genetic variability among individuals represented in the experiment. In order to determine the range of individuals/conditions our model can represent, internal parameterization boundaries (as well as their associated contextual boundaries) must be determined.
Mapping as an alternative to sensitivity analysis: The problem of combinatorial complexity in the selection of model parameters is well-established in the computational/biological modeling communities (14) (15) (16) (17) (18) . In previous work (3), we utilized high-performance computing to demonstrate the need for comprehensive "data coverage" among possible model states as well as the importance of internal parameter variation (as compared to model structure) to capture the full range of biological heterogeneity seen clinically. Here, we have extended that work to consider both model internal parameterizations as well as the parameterization which describes the model perturbation that generates disease. We posit that parameter space mapping, which has recently been rendered tractable with the rise of machine learning, has more generalizable utility than a traditional sensitivity analysis; the rationale for this statement is described below and in (19) .
In a standard parameter sensitivity analysis (20) (21) (22) , the dependence of mode output on variance in a single parameter (or potentially a combination or parameters) is quantified. In a complex ABM, this process requires the consideration of a large number of potentially free parameters, making a comprehensive calibration difficult (23) (24) (25) (26) (27) and significantly diminishing the utility of traditional parameter sensitivity analysis techniques (28, 29) . These difficulties are compounded when considering the range of biological heterogeneity seen experimentally and clinically (3, 19) . Sensitivity analysis can be effective at characterizing certain dynamic processes of ABMs, however, when traditional sensitivity analysis is applied to the high-dimensional, complex parameter spaces seen in detailed ABMs, it precludes the consideration of alternate model rule configurations which can generate equally viable model outputs and behaviors. As an illustrative example, consider the following rule, present in the original version of the IIRABM, describing a term which contribute the differentiation switch from a Th0 cell into a Th1 or Th2 cell:
Where the ′ represent some constant values used to weight the individual contributions of the array of cytokines. One could perform a sensitivity analysis on a model consisting solely of this rule, however that analysis would miss import bio-plausible model calibrations/parameterizations. While the rule is coded this way in the model, this representation does not actually represent the assertion made by the rule. A more complete way to write this rule would be:
Where j sums over the complete set of cytokines on the model, Γ represents the concentration of a specific cytokine, and the constant weighting terms, = 0. Thus, a comprehensive sensitivity analysis must consider implicit zeros in model rule construction, which can vastly increase the size of the task. Additionally, the model may only be sensitive to certain parameters in a specific context. Consider a more generic version of the above rule (model parameterization 1), which hypothetically leads to biologically plausible model output:
Which more completely, would be written:
Where = 0. There is no supposition that this hypothetically calibrated rule is uniquely correct. Assume the existence of an additional/alternative calibrated rule (model parameterization 2), which leads to equally biologically plausible model output:
In a model parameterization 1, in which all cytokine multipliers are set to 0 except for cytokine 1 and cytokine 2, the model will appear more sensitive to cytokines 1 and 2 than the others. In model parameterization 2, the model will appear more sensitive to cytokine 5 and cytokine 6. A sensitivity analysis on one model parameterization is not valid for all other model parameterizations. A comprehensive sensitivity analysis would then have to incorporate the model configuration under which it is being performed, which is computationally intractable for all but the smallest of models. In order to render this task computationally tractable, we have employed a nested active learning approach in order to efficiently and comprehensively explore model parameter space.
Methods

EMEWS:
During the initial code development, the AL models were trained and integrated using the Extreme-scale Model Exploration With Swift (EMEWS) framework (30) (31) (32) (33) . EMEWS enables the creation of high-performance computing (HPC) workflows for implementing large-scale model exploration studies. Built on the general-purpose parallel scripting language Swift/T (34), multi-language tasks can be combined and run on the largest open science HPC resources (35) via both data-flow semantics and stateful resident tasks. The ability that EMEWS provides for incorporating model exploration algorithms such as AL, implemented in R or Python, allows for the direct use of the many libraries relevant to ML that are being actively developed and implemented as free and open source software.
Active Learning: Active learning (AL) is a sub-field of machine learning (ML) which focusses on finding the optimal selection of training data to be used to train a ML or statistical model (36) . AL can be used for classification (37, 38) or regression (39, 40) . AL is an ideal technique for modeling problems in which there is a large amount of unlabeled data and manually labelling that data is expensive. In these circumstances (specifically the costly data labelling) AL provides to most generalizable and accurate model for the cheapest cost, which for the purposes of this work, is computation time.
The lower-level AL procedure seeks to find the boundary of the parameter space deemed "clinically relevant" (3) as a function of four parameters which describe the context in which the IIRABM operates:
two measures of microbial virulence (invasiveness and toxigenesis), host resilience, and environmental toxicity. In this scheme, there are two classes: clinically relevant and not clinically relevant. We assume that there exists some function, = ( ⃑), ∈ ⊂ ℝ , ∈ ℝ which accurately classifies model context parameters can be approximated given input data from the training set:
= { , ( )} for = 1, … , . The NN model uses a binary cross-entropy (41) loss function, in which the loss is given by:
Where is the ground truth value and ̂ is the NN-approximated score. The AL algorithm begins with a randomly selected set of 20 points. The IIRABM simulation then runs a fixed number of stochastic replicates of the input points to determine class membership. This information is then used to train the ML model. The algorithm then ranks the remaining unlabeled parameterizations by class-membership uncertainty (see Eq. 1).
Those parameterizations whose class is most uncertain in the current ML model are then selected for labeling and the process repeats until a stopping criterion is reached; for the purposes of this work, once the cross-validation accuracy crossed 0.95, the algorithm was stopped.
The upper-level AL workflow uses a modified version of Dropout-based AL for regression presented in (40) . The goal of this AL-workflow is twofold: to predict the volume of CR space and to predict the centroid location of CR-space, given a model internal parameterization. For each regression task, we assume that there exists a function, = ( ⃑), ∈ ⊂ ℝ , ∈ ℝ which approximates a map of CR space as a function of internal model parameterization which comprises the training set: = { , ( )} for = 1, … , . The NN model uses a mean-squared error (MSE) loss function, given by:
Where is the ground truth value for either the CR volume or centroid and ̂ is value regressed by the NN. In this scheme, we utilize a four-layer fully-connected neural network with a 256-Dropout-128-Dropout architecture. The dropout layer (42) serves to provide a stochastic variability to the output of the NN.
[Insert Figure 1 ] We discretize the model's internal parameter space into 9 bins, representing augmentations or inhibitions to specific cytokine pathways, giving 40,353,607 potential internal model parameterizations. We begin by pre-selecting 10,000 of these internal parameterizations randomly; this random selection then makes up the available pool, ,of unlabeled data. From this pool, we begin the AL procedure by selecting 100 internal parameterizations randomly from . These internal parameterizations are then fed into the lower-level AL workflow, which is used to map the CR space and return an approximate volume and center-point. This data is then used to train the upper-level neural net (see Fig. 1 ). The trained NN is then used to predict the volume or centroid location for the remaining unlabeled data for 10 stochastic replicates (the dropout layer provides stochasticity). The parameterizations from which have the highest variance are selected for labeling, and this process repeats. Pseudocode for this procedure is given below:
1. Initialize training pool ; upper-level dataset ; , the maximum size of the dataset; and samples to be added on each iteration, 2. While | | < : 
Results
In the lower-level AL workflow, we map CR space as a function of four parameters, external to the IIRABM's internal rule set. An example of this space can be seen in Fig. 2 . In this figure, outcome spaces for patients with low environmental toxicity (toxicity=1) to high environmental toxicity (toxicity=10) are shown from left to right. Each point represents 4000 in silico patients (40 injury sizes, 100 stochastic replicates). Points are color-coded based on the outcomes generated. The CR space is shown in green.
[Insert Figure 2]
We utilized seven different ML models to map the CR space: Artificial Neural Network (43), Adaptive Boosting (44), Naïve Bayesian (45), Random Forest (46), TreeBag (47), AdaBoost M1 (48), BagFlexible Discriminant Analysis with Generalized Cross Validation (49) . We compare an ensemble of models to ensure we have selected an appropriate ML strategy to explore the model in the most efficient manner. Results from this are shown in Fig. 3 , which displays the F-score as a function of AL iteration number (and by proxy, dataset size).
[Insert Figure 3]
It is readily apparent that a NN is the best type of ML model for mapping this space. By iteration 10, which uses 1000 parameterizations (out of 8800 possible), we can achieve an average class-prediction accuracy of >98%. The resulting ML model is then utilized to efficiently calculate the location and centroid of the CR space and train the upper-level neural net. This is due to the ease with which NN's can approximate nonlinear functions (50) . We present an illustration of this in Figure 4 , which displays three unique clinically relevant spaces for three unique internal model parameterizations, in a threedimensional slice of a four-dimensional perturbation-parameter space. The legend refers to an exponent determining the strength of augmentation or inhibition for all pathways; the meaning of and rationale for this exponent are described in detail in (6) . Red points labelled as 'Unique -1' are those points that are unique to the parameterization in which all protein synthesis pathways are inhibited by 90% (10 -1 of the uninhibited pathway secretion). Green points are unique to the parameterization in which all protein synthesis pathways are augmented by a factor of 10 1 . Teal points are unique to the parameterization in which all protein synthesis pathways are unchanged. Black points are those shared by the maximally inhibited and unchanged protein synthesis pathways.
[Insert Figure 4]
Results from the upper-level AL procedure are shown in Figure 5 . In panel A, we display the percent volume error as a function of the number of training samples for AL, Random Sampling (RS), and "Actively Not Learning" (ANL). ANL refers to utilizing the opposite of the AL sampling criterion. In this case, for AL we chose samples that maximized prediction variance; for ANL, we chose samples that minimized prediction variance. As expected, AL outperforms RS and requires fewer samples to converge to the error minimum. Additionally, both methods significantly outperform ANL, as expected. In Panel B, we show the standard deviation of the error for the previous three methods. Here, AL significantly outperforms RS in that the intelligent sampling criterion leads to a suite of models with a larger degree of precision in the volume prediction, whereas the changes in standard deviation of the error are minimal for ANL and minimal for RS after the first few samples. Panel C displays the error (as a Euclidean distance from the predicted centroid point to the true value) as a function of the number of samples. Once again, AL outperforms RS, though by a relatively modest amount.
[Insert Figure 5] 
Discussion
One of the primary goals and benefits of agent-based modeling is to use the computational model as an experimental proxy system (51) detailed enough to capture the vital aspects of patients and their associated clinical setting. The quest for increasingly detailed representation when using ABMs is a manifestation of the concurrent increase in mechanistic knowledge acquired from ongoing research; the consequence of these highly detailed models is that they contain a multitude of parameters within a highly connected set of rules and/or equations. The perception of intractability of effectively parameterizing such models is considered a major limitation in their use. Our prior work has demonstrated the need to operate with these models across a wide range of their parameter space, which we consider a representation of genetic variability with regards to pathway responsiveness among a clinical population (3) the work presented herein provides a demonstration of methods with which these parameter spaces can be identified.
We have described a nested active learning workflow which efficiently and accurately can characterize a high-dimensional and complex mechanism-based multi-scale model. We remove inefficiencies due to oversampling small regions of parameter space using the Monte-Carlo Dropout Uncertainty Estimation approach (40) . We note that AL outperforms RS in both the volume and centroid location predictions, but the greatest strength comes from the significant increase in precision generated by a suite of AL-trained models. This work demonstrates that comprehensive (and accurate) exploration of computational models with many parameters is both possible and computationally tractable, given current techniques in machine learning and high-performance computing. Additionally, while in some circumstances, the gains offered by AL are modest, it does help to minimize the cost of the computation.
In order to increase the utility of this work, we will develop higher resolution maps by labeling external parameter points individually rather than regressing the volume and centroid of the CR space. This will likely include collapsing the nested AL structure into a single network which takes internal and external parameterizations simultaneously, sacrificing some efficiency gained by the nested structure for increased precision in class identification. Pre-trained models can be incorporated into the development and training of control strategies by enabling the selection of disease conditions with specific cytokine dynamics and mortality rates without a computationally expensive search process.
The ultimate goal of this method when applied to any computational model would be the generation of a relatively compact data structure, in this case, one or more pre-trained neural networks, which accurately predicts some feature of interest to the computational model; in this case, that feature is whether or not a specific individual (internal model parameterization/model content) will certainly live or die when it experiences a specific perturbation (perturbation parameterization/model context). The appropriate threshold for 'accuracy' can be determined based on the specific requirements of the application to which it is applied as well as considering the diminishing returns to ML-model prediction accuracy as the number of training samples increases. This research is based upon work supported by the U. Outcome spaces for patients with low environmental toxicity (toxicity=1) to high environmental toxicity (toxicity=10) are shown from left to right. Each point represents 4000 in silico patients (40 injury sizes, each with 100 stochastic replicates). Points are color-coded based on the outcomes generated. Blue points represent simulations that healed under all circumstances. These points are distributed in regions of space where host resilience is high and the bacterial virulence is low (lower invasiveness and lower toxigenesis). Red points represent simulations that always died from overwhelming infection; these points are distributed in regions of high bacterial virulence (higher values for invasiveness and toxigenesis). Black points represent simulations that either died from overwhelming infection or healed completely and mark the boundary between simulations that always heal and simulations always die from infection. Pink points represent simulations which either died from overwhelming infection or hyperinflammatory system failure; these points are found primarily in the simulations that were treated with antibiotics and had low values for environmental toxicity and host resilience. Green points represent the Clinically Relevant simulations as these parameter sets lead to all possible outcomes; these points are distributed in regions of low to middle values of the host resilience parameter and moderately virulent infections. For all classes of simulation, the final outcomes are primarily dependent on the host resilience and microbial virulence , and Actively Not Learning (ANL), in which the learning criterion is the opposite of the AL criterion. We see that AL arrives at a more accurate prediction with fewer samples than RS or ANL. In Panel B, we show the standard deviation of the error of the volume prediction for the three above methods and note that AL not only generates a suite of more accurate models, but also has a much higher degree of precision. In Panel C, we show the error (in this case a Euclidean distance) in the centroid location prediction. AL once again outperforms RL.
